March 18, 2026 – Perceptive Imaging, the leading independent imaging core lab for the clinical research community, today announced the appointments of Matt Burnett as Chief Strategy Officer (CSO) and Sean Leech as Chief Operating Officer (COO). The appointments reflect Perceptive Imaging’s continued momentum as it expands its platform capabilities and supports an increasing volume and complexity of clinical trials worldwide.
“As the clinical development landscape continues to evolve, Perceptive Imaging is focused on ensuring our platforms and delivery capabilities keep pace with the expectations of today’s leading clinical trial sponsors, while upholding the scientific rigor required to support high‑stakes clinical and regulatory decisions,” said Doug Fulling, Chief Executive Officer of Perceptive Imaging. “The appointments of Matt and Sean reflect that commitment. Their combined experience driving strategy, AI-enabled platforms, and global delivery excellence positions us well to support the next phase of growth for both our clients and our business.”
As Chief Strategy Officer, Matt Burnett will lead Perceptive Imaging’s platform and AI innovation, ensuring that new capabilities are scaled effectively across the organization and that benefits are shared with customers. Burnett brings more than 25 years of experience across the clinical and life sciences industries, including leadership roles at Ideagen and Dotmatics-Siemens, with a track record of creating and launching AI-augmented SaaS platforms for heavily regulated environments. “Clinical trial imaging is more than data; it is the lens through which life-changing health outcomes are made possible,” said Matt Burnett, Chief Strategy Officer of Perceptive Imaging. “I’m excited to join Perceptive Imaging and work with the team to bring the next iteration of our imaging platform to market.”
Sean Leech joins Perceptive Imaging as Chief Operating Officer, where he will lead global delivery operations, with responsibility for ensuring consistent, high-quality execution as the company continues to scale. Leech brings more than 30 years of executive experience across the global life sciences and healthcare services industry, including leadership roles at ICON plc and PRA Health Sciences, with a track record of leading complex, technology-enabled operating models in the clinical trial space.
“With a strong scientific foundation and a longstanding reputation for excellence, Perceptive Imaging is well positioned for continued growth,” said Sean Leech, Chief Operating Officer of Perceptive Imaging. “I’m looking forward to working with the team to support delivery at scale and ensure a consistent, high-quality experience for sponsors’ growing demands.”
Together, Burnett and Leech bring complementary leadership skills across platform strategy and global delivery execution. Their appointments reflect the organization’s commitment to evolving its technology and delivery model in step with the changing needs of today’s leading clinical trial sponsors, building on a track record that includes support for more than 430 regulatory approvals worldwide, and supporting innovation at scale while maintaining the quality and reliability that imaging trials require.
About Perceptive Imaging
Perceptive Imaging is a leading global provider of high-quality clinical trial imaging services for the worldwide clinical research community. Built on market-leading scientific expertise, scalable operations, and a firm commitment to client success, Perceptive Imaging helps global pharmaceutical, biotech, and clinical research organizations accelerate the delivery of life-saving treatments to millions of patients around the world. With operations in Europe, North America, China, and India, Perceptive has supported 25% of all imaging studies since 1997.
Reach out today and one of our solution experts will be in touch to learn about your specific needs.
"*" indicates required fields
Δ
